SUO Clinical Trials Consortium Overview
About Us >
General Overview
Created, owned and operated by its members, the Society of Urological Oncology Clinical Trials Consortium (SUO-CTC) is a clinical research investigator network. The Consortium is a national alliance of leading academic and community based uro-oncologists committed to furthering urology research in the United States including pharmaceutical trials. The SUO-CTC is a not-for-profit corporation and has a cooperative relationship with the Society of Urologic Oncology.
SUO-CTC pursues clinical trials in concert with the pharmaceutical industry to find medicines and cures to tackle urological disorders including, but not restricted to:
- Bladder Cancer
- Prostate Cancer
- Renal Cancer
Together with industry, the SUO-CTC offers enhanced research options for ultimately delivering better quality of life.
SUO-CTC Operations
With Headquarters in Schaumburg, Illinois (approximately 8 miles NW of O’Hare International Airport), the SUO-CTC regularly receives queries from industry and other interested parties. The SUO-CTC Headquarters is equipped to quickly provide centralized communications for a variety of projects such as feasibility surveys, expedited reviews of clinical trials, capability assessments of research sites or membership on advisory boards.
Potential study sponsors deal directly with the Consortium instead of contacting each individual site. The full membership is continuously informed of the projects proposed to the Consortium and what stage of development they are in.
SUO-CTC Mission
- To offer and provide for the best possible approach to disease education and management providing for better patient outcomes.
- To provide education for the profession to further the learnings conducted through the profession (educate professionals to perform or allow them to perform at a higher level).
- To allow clinicians to be aware of existing research, which advances further clinical education and hypotheses. Through collaborative educational processes, patients benefit through the development of better therapies or clinical understandings.
The SUO-CTC helps to improve research options, which ultimately deliver better quality of life to Americans.
The SUO-CTC members improve research by:
- Providing a uro-oncolgic specific focus and concentration of expertise
- Facilitating rapid accrual to clinical trials
- Centralized study budgets & site selection
- Expert Investigators with patient populations
- Fast track communications
- Building and managing national resources to benefit physicians, pharmaceutical industry and the public
- Providing an efficient professional business approach based on fairness, transparency and credibility
- Setting standards for clinical research and clinical trial performance
- Collectively offering enhanced treatment options
- Building awareness campaigns and continued medical education
- Manuscript / abstract preparation
- Regulatory applications / Assignment of Senior Medical Officers (SMO’s)
SUO-CTC Giving Back of Knowledge, Information & Services
SUO-CTC's success will be measured in our 'giving-back' of knowledge, information and services through:
- Networked clinical trial performance
- Enhanced clinical trial productivity
- Growth in attracting industry players to the SUO-CTC
- International outreach to the uro-oncology community
- Publication of research
- Self-sufficiency and credibility
- Leading urology clinical research in new directions to achieve excellence in clinical care
|